Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class ASSE: 688621

Announcement on Convening Investor Briefing on Major Asset Restructuring Matters

· Issued by Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening Investor Briefing on Major Asset Restructuring Matters

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment